Literature DB >> 23628463

Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.

Sayed Ali Roudbari1, Malek Moien Ansar, Alireza Yousefzad.   

Abstract

BACKGROUND: Cigarette smoking seems to contribute to susceptibility and progression of multiple sclerosis (MS).Although the incidence of MS in Iranian population has increased during recent years, the effects of smoking on progression of MS have not been studied. The aim of this study was to investigate the association between cigarette smoking and development of secondary progressive MS (SPMS) in Iranian patients with MS.
METHODS: This study was carried out on patients registered in the MS Society (Guilan, Iran) database. Using a structured questionnaire, information on smoking status of 400 of patients could be obtained. The association between cigarettes smoking and SPMS was analyzed by Cox regression model.
RESULTS: The relationship between smoking and development of SPMS was still evident after adjusting for age at disease onset, gender and number of relapses per year (P =0.004). Smoking more than 10 cigarettes per day increased risk of development of SPMS (HR: 2.43; 95% CI: 1.28 to 4.6; P =0.007).
CONCLUSIONS: Our results indicated that smokers have an increased risk for progression of relapsing-remitting MS (RRMS) to SPMS compared with non-smokers. We also showed that the disease progression may be influenced by increase of cigarette smoking.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23628463     DOI: 10.1016/j.jns.2013.04.003

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

Review 1.  Wellness and the Role of Comorbidities in Multiple Sclerosis.

Authors:  Brandon P Moss; Mary R Rensel; Carrie M Hersh
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Effect of tobacco use on disease activity and DMT discontinuation in multiple sclerosis patients treated with dimethyl fumarate or fingolimod.

Authors:  Carrie M Hersh; Haleigh Harris; Malissa Ayers; Devon Conway
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-10-13

3.  Little evidence for an effect of smoking on multiple sclerosis risk: A Mendelian Randomization study.

Authors:  Ruth E Mitchell; Kirsty Bates; Robyn E Wootton; Adil Harroud; J Brent Richards; George Davey Smith; Marcus R Munafò
Journal:  PLoS Biol       Date:  2020-11-30       Impact factor: 8.029

4.  No association of tobacco use and disease activity in multiple sclerosis.

Authors:  Silje Kvistad; Kjell-Morten Myhr; Trygve Holmøy; Jūratė Šaltytė Benth; Kristin I Løken-Amsrud; Stig Wergeland; Antonie G Beiske; Kristian S Bjerve; Harald Hovdal; Finn Lilleås; Rune Midgard; Tom Pedersen; Søren J Bakke; Øivind Torkildsen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.